A year-long study of the spatial occurrence and relative distribution of pharmaceutical residues in sewage effluent, receiving marine waters and marine bivalves

Science of the Total Environment

Volumn 476-477, Issue , 2014, Pages 317-326

  McEneff, Gillian ^a,b   Barron, Leon ^c   Kelleher, Brian ^a   Paull, Brett ^d   Quinn, Brian ^b,e  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b Atlantic Technological University   (Ireland)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF TASMANIA   (Australia)

^e UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

Author keywords

Effluent; Liquid chromatography; Marine bivalves; Marine water; Mass spectrometry; Pharmaceuticals

Indexed keywords

AMIDES; ANTIBIOTICS; DRUG PRODUCTS; ECOSYSTEMS; EFFLUENTS; HISTOLOGY; LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETRY; MOLLUSCS; PHASE SEPARATION; RISK ASSESSMENT; SEWAGE; SURFACE WATERS; TISSUE;

CORRELATION COEFFICIENT; LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY (LC MS/MS); MARINE BIVALVES; MARINE WATERS; NON-STEROIDAL ANTI-INFLAMMATORY DRUGS; PHARMACEUTICAL RESIDUES; PRESSURISED LIQUID EXTRACTION; SOLID-PHASE EXTRACTION;

EXTRACTION;

CARBAMAZEPINE; DICLOFENAC; DRUG RESIDUE; GEMFIBROZIL; MEFENAMIC ACID; SEA WATER; TRIMETHOPRIM;

BIOACCUMULATION; BIVALVE; CONCENTRATION (COMPOSITION); DETECTION METHOD; DRUG; EFFLUENT; LIPID; LIQUID CHROMATOGRAPHY; MARINE ECOSYSTEM; MASS SPECTROMETRY; QUANTITATIVE ANALYSIS; SEWAGE; SPATIAL ANALYSIS;

ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; COASTAL WATERS; CONTROLLED STUDY; DRY WEIGHT; EXTRACTION; IRELAND; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MYTILUS; NONHUMAN; PRESSURIZED LIQUID EXTRACTION; PRIORITY JOURNAL; RISK ASSESSMENT; SEA SURFACE WATERS; SEWAGE EFFLUENT; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

EFFLUENT; LIQUID CHROMATOGRAPHY; MARINE BIVALVES; MARINE WATER; MASS SPECTROMETRY; PHARMACEUTICALS;

ANIMALS; BIVALVIA; ENVIRONMENTAL MONITORING; PHARMACEUTICAL PREPARATIONS; SEAWATER; SEWAGE; WASTE DISPOSAL, FLUID; WASTE WATER; WATER POLLUTANTS, CHEMICAL;

EID: 84892999646     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2013.12.123     Document Type: Article

References (66)

1. Prescriptions dispensed in the community: England statistics for 1999 to 2009 2010, The National Health Scheme Information Centre of England, England.
2. Primary care reimbursement service: statistical analysis of claims and payments 2010, Irish Health Service Executive, Dublin.
3. Adams C., Wang Y., Loftin K., Meyer M. Removal of antibiotics from surface and distilled water in conventional water treatment processes. J Environ Eng ASCE 2002, 128:253-260.
4. Barron L., Havel J., Purcell M., Szpak M., Kelleher B., Paull B. Predicting sorption of pharmaceuticals and personal care products onto soil and digested sludge using artificial neural networks. Analyst 2009, 134:663-670.
5. Barron L., Nesterenko E., Hart K., Power E., Quinn B., Kelleher B., et al. Holistic visualisation of the multimodal transport and fate of twelve pharmaceuticals in biosolid enriched topsoils. Anal Bioanal Chem 2010, 397:287-296.
6. Barron L., Tobin J., Paull B. Multi-residue determination of pharmaceuticals in sludge and sludge enriched soils using pressurized liquid extraction, solid phase extraction and liquid chromatography with tandem mass spectrometry. J Environ Monit 2008, 10:353-361.
7. Benotti M.J., Trenholm R.A., Vanderford B.J., Holady J.C., Stanford B.D., Snyder S.A. Pharmaceuticals and endocrine disrupting compounds in US drinking water. Environ Sci Technol 2009, 43:597-603.
8. Bones J., Nesterenko P., Thomas K., Paul B. Dual gradient LC method for the determination of pharmaceutical residues in environmental samples using a monolithic silica reversed phase column. Int J Environ Anal Chem 2006, 86:487-504.
9. Boxall A.B.A. The environmental side effects of medication - how are human and veterinary medicines in soils and water bodies affecting human and environmental health?. EMBO Rep 2004, 5:1110-1116.
10. Bringolf R.B., Heltsley R.M., Newton T.J., Eads C.B., Fraley S.J., Shea D., et al. Environmental occurrence and reproductive effects of the pharmaceutical fluoxetine in native freshwater mussels. Environ Toxicol Chem 2010, 29:1311-1318.
11. Brooks B.W., Chambliss C.K., Stanley J.K., Ramirez A., Banks K.E., Johnson R.D., et al. Determination of select antidepressants in fish from an effluent-dominated stream. Environ Toxicol Chem 2005, 24:464-469.
12. Brown J.N., Paxeus N., Forlin L., Larsson D.G.J. Variations in bioconcentration of human pharmaceuticals from sewage effluents into fish blood plasma. Environ Toxicol Pharmacol 2007, 24:267-274.
13. Bueno M.J.M., Boillot C., Fenet H., Chiron S., Cassellas C., Gomez E. Fast and easy extraction combined with high resolution-mass spectrometry for residue analysis of two anticonvulsants and their transformation products in marine mussels. J Chromatogr A 2013, 1305:27-34.
14. Buser H.R., Muller M.D., Theobald N. Occurrence of the pharmaceutical drug clofibric acid and the herbicide mecoprop in various Swiss lakes and in the North Sea. Environ Sci Technol 1998, 32:188-192.
15. Cabello F.C. Heavy use of prophylactic antibiotics in aquaculture: a growing problem for human and animal health and for the environment. Environ Microbiol 2006, 8:1137-1144.
16. Clara M., Kreuzinger N., Strenn B., Gans O., Kroiss H. The solids retention time - a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants. Water Res 2005, 39:97-106.
17. Contardo-Jara V., Lorenz C., Pflugmacher S., Nutzmann G., Kloas W., Wiegand C. Exposure to human pharmaceuticals carbamazepine, ibuprofen and bezafibrate causes molecular effects in Dreissena polymorpha. Aquat Toxicol 2011, 105:428-437.
18. Cuklev F., Kristiansson E., Fick J., Asker N., Forlin L., Larsson D.G.J. Diclofenac in fish: blood plasma levels similar to human therapeutic levels affect global hepatic gene expression. Environ Toxicol Chem 2011, 30:2126-2134.
19. Debska J., Kot-Wasik A., Namiesnik J. Fate and analysis of pharmaceutical residues in the aquatic environment. Crit Rev Anal Chem 2004, 34:51-67.
20. EU Regulation 37/2010 European Commission Regulation no. 37/2010 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin. Off J Eur Communities 2009, 5:1-72.
21. Fatta-Kassinos D., Meric S., Nikolaou A. Pharmaceutical residues in environmental waters and wastewater: current state of knowledge and future research. Anal Bioanal Chem 2011, 399:251-275.
22. Fent K., Weston A.A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquat Toxicol 2006, 76:122-159.
23. Fick J., Lindberg R.H., Parkkonen J., Arvidsson B., Tysklind M., Larsson D.G.J. Therapeutic levels of levonorgestrel detected in blood plasma of fish: results from screening rainbow trout exposed to treated sewage effluents. Environ Sci Technol 2010, 44:2661-2666.
24. Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol Lett 2002, 131:5-17.
25. Heberer T., Fuhrmann B., Schmidt-Baumler K., Tsipi D., Koutsouba V., Hiskia A. Occurrence of pharmaceutical residues in sewage, river, ground-, and drinking water in Greece and Germany. Abstr Pap Am Chem Soc 2000, 219:U623-U.
26. Heberer T., Reddersen K., Mechlinski A. From municipal sewage to drinking water: fate and removal of pharmaceutical residues in the aquatic environment in urban areas. Water Sci Technol 2002, 46:81-88.
27. Hernando M.D., Mezcua M., Fernandez-Alba A.R., Barcelo D. Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta 2006, 69:334-342.
28. Huerta B., Jakimska A., Gros M., Rodriguez-Mozaz S., Barcelo D. Analysis of multi-class pharmaceuticals in fish tissues by ultra-high-performance liquid chromatography tandem mass spectrometry. J Chromatogr A 2013, 1288:63-72.
29. Huerta B., Rodriguez-Mozaz S., Barcelo D. Pharmaceuticals in biota in the aquatic environment: analytical methods and environmental implications. Anal Bioanal Chem 2012, 404:2611-2624.
30. Hunt C.D., Slone E. Long-term monitoring using resident and caged mussels in Boston Harbor yield similar spatial and temporal trends in chemical contamination. Mar Environ Res 2010, 70:343-357.
31. Jelic A., Gros M., Ginebreda A., Cespedes-Sanchez R., Ventura F., Petrovic M., et al. Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment. Water Res 2011, 45:1165-1176.
32. Klosterhaus S.L., Grace R., Hamilton M.C., Yee D. Method validation and reconnaissance of pharmaceuticals, personal care products, and alkylphenols in surface waters, sediments, and mussels in an urban estuary. Environ Int 2013, 54:92-99.
33. Lacey C., McMahon G., Bones J., Barron L., Morrissey A., Tobin J.M. An LC-MS method for the determination of pharmaceutical compounds in wastewater treatment plant influent and effluent samples. Talanta 2008, 75:1089-1097.
34. Lacey C., Basha S., Morrissey A., Tobin J.M. Occurrence of pharmaceutical compounds in wastewater process streams in Dublin. Ireland. Environ Monit Assess 2012, 184:1049-1062.
35. Lahti M., Brozinski J.M., Jylha A., Kronberg L., Oikari A. Uptake from water, biotransformation, and biliary excretion of pharmaceuticals by rainbow trout. Environ Toxicol Chem 2011, 30:1403-1411.
36. Lajeunesse A., Gagnon C., Gagne F., Louis S., Cejka P., Sauve S. Distribution of antidepressants and their metabolites in brook trout exposed to municipal wastewaters before and after ozone treatment - evidence of biological effects. Chemosphere 2011, 83:564-571.
37. Langford K., Thomas K.V. Input of selected human pharmaceutical metabolites into the Norwegian aquatic environment. J Environ Monit 2011, 13:416-421.
38. Lapworth D.J., Baran N., Stuart M.E., Ward R.S. Emerging organic contaminants in groundwater: a review of sources, fate and occurrence. Environ Pollut 2012, 163:287-303.
39. Li W.H., Shi Y.L., Gao L.H., Liu J.M., Cai Y.Q. Investigation of antibiotics in mollusks from coastal waters in the Bohai Sea of China. Environ Pollut 2012, 162:56-62.
40. Lishman L., Smyth S.A., Sarafin K., Kleywegt S., Toito J., Peart T., et al. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada. Sci Total Environ 2006, 367:544-558.
41. McEneff G., Barron L., Kelleher B., Paull B., Quinn B. The determination of pharmaceutical residues in cooked and uncooked marine bivalves using pressurised liquid extraction, solid phase extraction and liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 2013, 405:9509-9521.
42. Mehinto A.C., Hill E.M., Tyler C.R. Uptake and biological effects of environmentally relevant concentrations of the nonsteroidal anti-inflammatory pharmaceutical diclofenac in rainbow trout (Oncorhynchus mykiss). Environ Sci Technol 2010, 44:2176-2182.
43. Meredith-Williams M., Carter L.J., Fussell R., Raffaelli D., Ashauer R., Boxall A.B.A. Uptake and depuration of pharmaceuticals in aquatic invertebrates. Environ Pollut 2012, 165:250-258.
44. Monirith I., Ueno D., Takahashi S., Nakata H., Sudaryanto A., Subramanian A., et al. Asia-Pacific mussel watch: monitoring contamination of persistent organochlorine compounds in coastal waters of Asian countries. Mar Pollut Bull 2003, 46:281-300.
45. Quinn B., Gagne F., Blaise C. Oxidative metabolism activity in Hydra attenuata exposed to carbamazepine. Fresenius Environ Bull 2004, 13:783-788.
46. Quinn B., Schmidt W., O'Rourke K., Hernan R. Effects of the pharmaceuticals gemfibrozil and diclofenac on biomarker expression in the zebra mussel (Dreissena polymorpha) and their comparison with standardised toxicity tests. Chemosphere 2011, 84:657-663.
47. Roberts P.H., Thomas K.V. The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. Sci Total Environ 2006, 356:143-153.
48. Ronan J.M., McHugh B. A sensitive liquid chromatography/tandem mass spectrometry method for the determination of natural and synthetic steroid estrogens in seawater and marine biota, with a focus on proposed Water Framework Directive Environmental Quality Standards. Rapid Commun Mass Spectrom 2013, 27:738-746.
49. Schmidt W., O'Rourke K., Hernan R., Quinn B. Effects of the pharmaceuticals gemfibrozil and diclofenac on the marine mussel (Mytilus spp.) and their comparison with standardized toxicity tests. Mar Pollut Bull 2011, 62:1389-1395.
50. Schmidt W., Rainville L.-C., McEneff G., Sheehan D., Quinn B. A proteomic evaluation of the effects of the pharmaceuticals diclofenac and gemfibrozil on marine mussels (Mytilus spp.): evidence for chronic sublethal effects on stress-response proteins. Drug Test Anal 2013, 10.1002/dta.1463.
51. Schwaiger J., Ferling H., Mallow U., Wintermayr H., Negele R.D. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part 1: histopathological alterations and bioaccumulation in rainbow trout. Aquat Toxicol 2004, 68:141-150.
52. Stan H.J., Heberer T. Pharmaceuticals in the aquatic environment. Analusis 1997, 25:M20-M23.
53. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res 1998, 32:3245-3260.
54. Ternes T.A., Kreckel P., Mueller J. Behaviour and occurrence of estrogens in municipal sewage treatment plants - II. Aerobic batch experiments with activated sludge. Sci Total Environ 1999, 225:91-99.
55. Thomas K.V., Hilton M.J. The occurrence of selected human pharmaceutical compounds in UK estuaries. Mar Pollut Bull 2004, 49:436-444.
56. Togunde O.P., Oakes K.D., Servos M.R., Pawliszyn J. Determination of pharmaceutical residues in fish bile by solid-phase microextraction couple with liquid chromatography-tandem mass spectrometry (LC/MS/MS). Environ Sci Technol 2012, 46:5302-5309.
57. Triebskorn R., Casper H., Scheil V., Schwaiger J. Ultrastructural effects of pharmaceuticals (carbamazepine, clofibric acid, metoprolol, diclofenac) in rainbow trout (Oncorhynchus mykiss) and common carp (Cyprinus carpio). Anal Bioanal Chem 2007, 387:1405-1416.
58. Uno K. Oxytetracycline and oxolinic acid residues in kuruma prawn (Penaeus japonicus) and the effect of cooking procedures on the residues. J Food Hyg Soc Jpn 2002, 43:62-67.
59. Uno K., Aoki T., Kleechaya W., Ruangpan L., Tanasomwang V. Pharmacokinetics of oxolinic acid in black tiger shrimp, Penaeus monodon Fabricius, and the effect of cooking on residues. Aquac Res 2006, 37:826-833.
60. Uno K., Aoki T., Kleechaya W., Tanasomwang V., Ruangpan L. Pharmacokinetics of oxytetracycline in black tiger shrimp, Penaeus monodon, and the effect of cooking on the residues. Aquaculture 2006, 254:24-31.
61. Uno K., Chaweepack T., Ruangpan L. Pharmacokinetics and bioavailability of oxytetracycline in vannamei shrimp (Penaeus vannamei) and the effect of processing on the residues in muscle and shell. Aquac Int 2010, 18:1003-1015.
62. Vieno N., Tuhkanen T., Kronberg L. Elimination of pharmaceuticals in sewage treatment plants in Finland. Water Res 2007, 41:1001-1012.
63. Weigel S., Kuhlmann J., Huhnerfuss H. Drugs and personal care products as ubiquitous pollutants: occurrence and distribution of clofibric acid, caffeine and DEET in the North Sea. Sci Total Environ 2002, 295:131-141.
64. Weigel S., Berger U., Jensen E., Kallenborn R., Thoresen H., Huhnerfuss H. Determination of selected pharmaceuticals and caffeine in sewage and seawater from Tromso/Norway with emphasis on ibuprofen and its metabolites. Chemosphere 2004, 56:583-592.
65. Wille K., Kiebooms J.A.L., Claessens M., Rappe K., Vanden Bussche J., Noppe H., et al. Development of analytical strategies using U-HPLC-MS/MS and LC-ToF-MS for the quantification of micropollutants in marine organisms. Anal Bioanal Chem 2011, 400:1459-1472.
66. Wille K., Noppe H., Verheyden K., Vanden Bussche J., De Wulf E., Van Caeter P., et al. Validation and application of an LC-MS/MS method for the simultaneous quantification of 13 pharmaceuticals in seawater. Anal Bioanal Chem 2010, 397:1797-1808.